Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AUP Aurinia Pharmaceuticals		C$0.00	C$11.77 ▼ C$26.00	C$2.15B	N/A	229,895 shs	4.61 million shs
CARA Cara Therapeutics		$15.19	$8.13 ▼ $19.08	$24.33M	0.41	22,224 shs	237,144 shs
PYR PyroGenesis Canada	$0.38	$0.38	$0.26 ▼ $1.30	$67.96M	0.7	47,701 shs	29,889 shs
TLRY Tilray Brands	$1.15 +3.6%	$0.66	$0.35 ▼ $1.95	$1.22B	1.85	76.17 million shs	51.16 million shs

5G Stocks: The Path Forward is Profitable

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AUP Aurinia Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	0.00%
CARA Cara Therapeutics	0.00%	0.00%	0.00%	0.00%	+29.93%
PYR PyroGenesis Canada	0.00%	0.00%	0.00%	0.00%	0.00%
TLRY Tilray Brands	+4.72%	-5.93%	+41.24%	+150.90%	-41.27%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AUP Aurinia Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CARA Cara Therapeutics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PYR PyroGenesis Canada	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TLRY Tilray Brands	2.6666 of 5 stars	3.1	1.0	0.0	0.0	3.8	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AUP Aurinia Pharmaceuticals	0.00	N/A	N/A	N/A
CARA Cara Therapeutics	0.00	N/A	N/A	N/A
PYR PyroGenesis Canada	0.00	N/A	N/A	N/A
TLRY Tilray Brands	2.20	Hold	$1.92	66.67% Upside

Current Analyst Ratings Breakdown

Latest PYR, AUP, CARA, and TLRY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
7/29/2025	TLRY Tilray Brands	Zelman & Associates Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral

(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AUP Aurinia Pharmaceuticals	C$57.59M	0.00	N/A	6.75	C$2.59 per share	0.00
CARA Cara Therapeutics	$7.14M	0.00	N/A	N/A	$12.58 per share	0.00
PYR PyroGenesis Canada	$14.63M	4.65	N/A	N/A	$0.07 per share	5.43
TLRY Tilray Brands	$821.31M	1.54	$0.15 per share	7.68	$1.40 per share	0.82

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AUP Aurinia Pharmaceuticals	N/A	-C$1.48	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CARA Cara Therapeutics	-$118.51M	-$21.01	N/A	N/A	N/A	-1,099.76%	-367.97%	-107.43%	N/A
PYR PyroGenesis Canada	-$24.74M	-$0.11	N/A	∞	N/A	-233.18%	-194.66%	-68.91%	N/A
TLRY Tilray Brands	-$2.19B	-$2.31	N/A	N/A	N/A	-265.69%	-6.83%	-5.45%	10/9/2025 (Estimated)

Latest PYR, AUP, CARA, and TLRY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
7/28/2025	Q4 2025	TLRY Tilray Brands	-$0.03	$0.02	+$0.05	-$1.30	$250.41 million	$224.54 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AUP Aurinia Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
CARA Cara Therapeutics	N/A	N/A	N/A	N/A	N/A
PYR PyroGenesis Canada	N/A	N/A	N/A	N/A	N/A
TLRY Tilray Brands	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AUP Aurinia Pharmaceuticals	2.69	11.93	11.02
CARA Cara Therapeutics	N/A	4.77	4.71
PYR PyroGenesis Canada	0.26	0.86	0.78
TLRY Tilray Brands	0.20	2.46	1.49

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AUP Aurinia Pharmaceuticals	N/A
CARA Cara Therapeutics	44.66%
PYR PyroGenesis Canada	0.41%
TLRY Tilray Brands	9.35%

Insider Ownership

Company	Insider Ownership
AUP Aurinia Pharmaceuticals	N/A
CARA Cara Therapeutics	3.10%
PYR PyroGenesis Canada	47.68%
TLRY Tilray Brands	0.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AUP Aurinia Pharmaceuticals	300	128.40 million	N/A	Not Optionable
CARA Cara Therapeutics	80	4.57 million	4.43 million	Optionable
PYR PyroGenesis Canada	2,020	178.88 million	93.59 million	Not Optionable
TLRY Tilray Brands	2,842	1.10 billion	1.09 billion	Optionable

PYR, AUP, CARA, and TLRY Headlines

Recent News About These Companies

Tilray Brands (NASDAQ:TLRY) Stock Price Up 3.3% - Here's What Happened

August 22 at 1:46 PM | marketbeat.com

Tilray Brands (NASDAQ:TLRY) Trading Down 3.3% - Time to Sell?

August 21 at 3:37 PM | marketbeat.com

Tilray's High Hopes: The Catalyst Driving Cannabis Stocks

...

August 21 at 2:09 PM | marketbeat.com

Top Cannabis Stocks To Watch Today - August 20th

August 21 at 1:11 PM | marketbeat.com

Unleashing the Spirit of Adventure: Breckenridge Distillery Launches Mountain Shot, a Bold New Mushroom-Infused Elixir

August 21 at 7:00 AM | globenewswire.com

Tilray Brands (NASDAQ:TLRY) Trading Down 7.5% - Time to Sell?

August 20 at 3:05 PM | marketbeat.com

Cannabis Stocks To Follow Today - August 19th

August 20 at 1:01 PM | marketbeat.com

Tilray Shares Blazing: What's Behind the 55% Rally This Month?

...

August 20 at 11:25 AM | marketbeat.com

If You'd Invested $1,000 in Tilray Stock 5 Years Ago, Here's How Much You'd Have Today

August 20 at 7:01 AM | fool.com

Tilray Brands (NASDAQ:TLRY) Shares Up 9.2% - Time to Buy?

August 19 at 3:11 PM | marketbeat.com

Promising Cannabis Stocks To Add to Your Watchlist - August 18th

August 19 at 2:30 PM | marketbeat.com

Tilray Brands (NASDAQ:TLRY) Shares Gap Up - Here's Why

August 19 at 12:47 PM | marketbeat.com

Tilray Brands (NASDAQ TLRY) Rises Amid NASDAQ Composite Market Trends

August 19 at 8:07 AM | kalkinemedia.comK

Promising Cannabis Stocks To Add to Your Watchlist - August 17th

August 18, 2025 | marketbeat.com

National Bank of Canada FI Sells 763,247 Shares of Tilray Brands, Inc. $TLRY

August 18, 2025 | marketbeat.com

Tilray Brands (TLRY) Boosts Revenue Mix with New Cannabis, Wellness, and Beverage Products

August 17, 2025 | insidermonkey.com

Cannabis Stocks Worth Watching - August 16th

August 17, 2025 | marketbeat.com

Best Canadian Cannabis Stocks in 2025

August 17, 2025 | marijuanastocks.comM

Tilray Brands (NASDAQ:TLRY) Trading Down 7.2% - Here's What Happened

August 16, 2025 | marketbeat.com

Best Cannabis Stocks To Follow Today - August 15th

August 16, 2025 | marketbeat.com

Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors

August 15, 2025 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

PYR, AUP, CARA, and TLRY Company Descriptions

Aurinia Pharmaceuticals TSE:AUP

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

Cara Therapeutics NASDAQ:CARA

Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.

PyroGenesis Canada NASDAQ:PYR

PyroGenesis Canada Inc. designs, develops, manufactures, and commercializes plasma processes and solutions worldwide. It offers DROSRITE, a process for enhancing metal recovery from dross without any hazardous by-products; plasma atomization process that allows produce and sell high purity spherical metal powders; PUREVAP, a process to produce high purity metallurgical and solar grade silicon from quartz; and PUREVAP NSiR, which is designed to transform silicon into spherical silicon nano powders and nanowires for use in lithium-ion batteries. The company also provides plasma torches and plasma torch systems used toreplace fossil fuel burners in industrial iron ore pelletization process; plasma arc waste destruction systems for waste destruction onboard ships; steam plasma arc refrigerant cracking systems for the destruction of certain refrigerants, including chlorofluorocarbons, hydrofluorocarbons, and hydrochlorofluorocarbons; plasma arc chemical warfare agent destruction systems, which are mobile platforms for the onsite destruction of chemical warfare agents; plasma resource recovery systems for land-based waste destruction and waste-to-energy applications; plasma torches for waste gasification and combustion; and plasma arc gasification and vitrification. In addition, it offers engineering and manufacturing expertise, and contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, additive manufacturing (including 3D printing), oil and gas, and environmental industries. Further, the company provides installation, commissioning, and start-up services. PyroGenesis Canada Inc. is headquartered in Montréal, Canada.

Tilray Brands NASDAQ:TLRY

$1.15 +0.04 (+3.60%)

Closing price 04:00 PM Eastern

Extended Trading

$1.14 0.00 (-0.43%)

As of 07:59 PM Eastern

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time